Hans Lentzen

1.1k total citations
42 papers, 966 citations indexed

About

Hans Lentzen is a scholar working on Immunology, Biotechnology and Molecular Biology. According to data from OpenAlex, Hans Lentzen has authored 42 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 20 papers in Biotechnology and 19 papers in Molecular Biology. Recurrent topics in Hans Lentzen's work include Toxin Mechanisms and Immunotoxins (24 papers), Transgenic Plants and Applications (20 papers) and Neuropeptides and Animal Physiology (6 papers). Hans Lentzen is often cited by papers focused on Toxin Mechanisms and Immunotoxins (24 papers), Transgenic Plants and Applications (20 papers) and Neuropeptides and Animal Physiology (6 papers). Hans Lentzen collaborates with scholars based in Germany, Switzerland and Austria. Hans Lentzen's co-authors include Martin Langer, Holger Zinke, Babette Möckel, Jürgen Eck, Katarina Hostanska, Tibor Hajtò, A. Philippu, Klaus Witthohn, J. Fischer and Giulio C. Spagnoli and has published in prestigious journals such as Biochemistry, Trends in Biochemical Sciences and Biochemical and Biophysical Research Communications.

In The Last Decade

Hans Lentzen

41 papers receiving 918 citations

Peers

Countries citing papers authored by Hans Lentzen

Since Specialization

Citations

This map shows the geographic impact of Hans Lentzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Lentzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Lentzen more than expected).

Fields of papers citing papers by Hans Lentzen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Lentzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Lentzen. The network helps show where Hans Lentzen may publish in the future.

Co-authorship network of co-authors of Hans Lentzen

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Lentzen. A scholar is included among the top collaborators of Hans Lentzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Lentzen. Hans Lentzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of microbial and transient expression (tobacco plants and plant‐cell packs) for the production and purification of the anticancer mistletoe lectin viscumin 2019 ·Biotechnology and Bioengineering ·(unknown), (unknown), Patrick Opdensteinen, (unknown), Georg Melmer, Hans Lentzen, (unknown), Johannes F. Buyel	39
2	Adjuvant Therapy Using Mistletoe Containing Drugs Boosts the T‐Cell‐Mediated Killing of Glioma Cells and Prolongs the Survival of Glioma Bearing Mice 2018 ·Evidence-based Complementary and Alternative Medicine ·(unknown), Stephan M. Huber, Hans Lentzen, Michel Mittelbronn, Ulrike Naumann	9
3	Viscumins functionally modulate cell motility-associated gene expression 2017 ·International Journal of Oncology ·(unknown), (unknown), Angela Armento, Vivien Veninga, Naita M. Wirsik, Simon Bernatz, Hans Lentzen, Michel Mittelbronn, Ulrike Naumann	15
4	Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study 2014 ·Journal for ImmunoTherapy of Cancer ·Uwe Trefzer, Ralf Gutzmer, Tabea Wilhelm, Florian Schenck, Katharina C. Kähler, (unknown), Klaus Witthohn, Hans Lentzen, Peter Mohr	7
5	The preclinical and clinical activity of aviscumine: A potential anticancer drug 2011 ·European Journal of Cancer ·H. Zwierzina, Lothar Bergmann, Heiner Fiebig, Steinar Aamdal, Patrick Schöffski, Klaus Witthohn, Hans Lentzen	41
6	Phase I trial of r viscumin (INN: aviscumine) given subcutaneously in patients with advanced cancer: A study of the European Organisation for Research and Treatment of Cancer (EORTC protocol number 13001) 2008 ·European Journal of Cancer ·Lothar Bergmann, (unknown), Sandrine Marréaud, Denis Lacombe, Manfred Herold, Takuhiro Yamaguchi, Karin Wilhelm-Ogunbiyi, Hans Lentzen, H. Zwierzina	18
7	Weekly 24h infusion of aviscumine (rViscumin): A phase I study in patients with solid tumours 2005 ·European Journal of Cancer ·Patrick Schöffski, (unknown), J Krauter, O. Bolte, Michael Stadler, Arnold Ganser, Karin Wilhelm-Ogunbiyi, Hans Lentzen	23
8	Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group 2004 ·Annals of Oncology ·P. Schöffski, (unknown), P. Fumoleau, Mario Campone, O. Bolte, Sandrine Marréaud, Denis Lacombe, B. Barón, Manfred Herold, H. Zwierzina, Karin Wilhelm-Ogunbiyi, Hans Lentzen, Chris Twelves	72
9	Cloning of the mistletoe lectin gene and characterization of the recombinant A‐chain 1999 ·European Journal of Biochemistry ·Jürgen Eck, Martin Langer, Babette Möckel, A. Baur, (unknown), Holger Zinke, Hans Lentzen	71
10	Characterization of recombinant and plant‐derived mistletoe lectin and their B‐chains 1999 ·European Journal of Biochemistry ·Jürgen Eck, Martin Langer, Babette Möckel, Klaus Witthohn, Holger Zinke, Hans Lentzen	71
11	Site-Specific Mutagenesis of Mistletoe Lectin: The Role of RIP Activity in Apoptosis 1999 ·Biochemical and Biophysical Research Communications ·Martin Langer, Babette Möckel, Jürgen Eck, Holger Zinke, Hans Lentzen	36
12	Selective Modulation of Phosphatidylserine Exposure on Subpopulations of Human Peripheral Blood Lymphocytes by a Plant Lectin, Viscum album Agglutinin (VAA)-I and its Recombinant Form (rVAA) in Vitro 1999 ·Cancer Detection and Prevention ·Katarina Hostanska, Tibor Hajtò, (unknown), U. Mengs, K. Weber, Hans Lentzen, Reinhard Saller	13
13	In Vitro Efficacy of Conjugates of Anti-CD45 Monoclonal Antibodies With Plant Toxin A-Chains 1998 ·Transplantation Proceedings ·(unknown), (unknown), И. И. Агапов, Abdijapar Shamshiev, (unknown), (unknown), (unknown), Rex A. Palmer, Hans Lentzen, Alexander Tonevitsky	2
14	Mistletoe lectin I forms a double trefoil structure 1998 ·FEBS Letters ·(unknown), Alexander Tonevitsky, Rex A. Palmer, Hideaki Niwa, (unknown), (unknown), Hans Lentzen, И. И. Агапов, М. П. Кирпичников	37
15	Effect of a Recombinant Lectin, <i>Viscum album</i> Agglutinin on the Secretion of Interleukin-12 in Cultured Human Peripheral Blood Mononuclear Cells and on NK-Cell-Mediated Cytotoxicity of Rat Splenocytes in vitro and in vivo 1998 ·PubMed ·Tibor Hajtò, Katarina Hostanska, Klaus Weber, Holger Zinke, (unknown), U. Mengs, Hans Lentzen, Reinhard Saller	64
16	In U-937 promonocytes, misteltoe lectin I increases basal [Ca2+]i, enhances histamine H1- and complement C5a-receptor-mediated rises in [Ca2+]i, and induces cell death 1997 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Katharina Wenzel‐Seifert, Hans Lentzen, Roland Seifert	11
17	Investigations of cellular parameters to establish the response of a biomodulator: galactoside-specific Lectin from Viscum album plant extract 1996 ·Phytomedicine ·Tibor Hajtò, Katarina Hostanska, J. Fischer, Hans Lentzen	13
18	Bioregulation of yeast plasma membrane ATPase and carnitin acetyl transferase (CAT) activity at defined metabolic states 1987 ·Journal of Biotechnology ·Hans Lentzen, (unknown), Othmar Käppeli, A. Fiechter, Günter Fred Fuhrmann	6
19	Localization of the thiorphan‐sensitive endopeptidase, termed enkephalinase A, on glial cells 1983 ·FEBS Letters ·Hans Lentzen, (unknown)	40
20	No evidence for enkephalinase A on neuronal cells 1983 ·Life Sciences ·Hans Lentzen, (unknown), (unknown), (unknown)	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact